Hypofractionation: Clinical Trials

6 trials of Hypofractionation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 1 completed, 1 not yet recruiting, 1 recruiting. 6 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Active not recruiting 2, Completed 1, Not yet recruiting 1, Recruiting 1, Suspended 1
Phase 23Active not recruiting 1, Not yet recruiting 1, Suspended 1

Follow Hypofractionation: new trials by email Literature Review of Hypofractionation trials Research Report on Hypofractionation

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy
Hypofractionation - Locally Advanced Cervical Carcinoma
Phase 1 / Phase 2Not yet recruitingUniversity of Santo Tomas Hospital, Philippines552024-01-012023-01-31
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
Carboplatin, Durvalumab, Paclitaxel - Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 1RecruitingOhio State University Comprehensive Cancer Center282021-12-062026-06-30
Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma
Bintrafusp Alfa, Biopsy, Hypofractionated Radiation Therapy - Locally Advanced Intrahepatic Cholangiocarcinoma, Metastatic Intrahepatic Cholangiocarcinoma
Phase 1Active not recruitingM.D. Anderson Cancer Center22021-08-312026-09-14
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8
Phase 1 / Phase 2SuspendedNational Cancer Institute (NCI)922021-01-112026-10-20
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
Avelumab, Biopsy Procedure, Biospecimen Collection - Locally Advanced Malignant Solid Neoplasm, Locally Advanced Unresectable Cholangiocarcinoma
Phase 1 / Phase 2Active not recruitingNational Cancer Institute (NCI)1032020-04-072026-10-02
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer
Hypofractionated Radiation Therapy, Losartan, Losartan Potassium - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma
Phase 1CompletedUniversity of Utah222019-08-082026-07-06

Conditions studied

Cholangiocarcinoma (2)  ·  Pancreatic Neoplasms (2)  ·  Gallbladder Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasm Metastasis (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  M.D. Anderson Cancer Center (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  University of Santo Tomas Hospital, Philippines (1)  ·  University of Utah (1)

Countries

United States (5)

Top investigators

Eugene J Koay (1)  ·  Jeremey Brownstein, MD (1)  ·  Kristen R Spencer (1)  ·  Sarah L Davis (1)  ·  Shane Lloyd (1)  ·  Warren Bacorro, MD (1)

NIH funding

R01CA262388 (1), UM1CA186644 (1), UM1CA186691 (1), UM1CA186716 (1)